Treatment rationale and study design for a randomized trial of pemetrexed/carboplatin followed by maintenance pemetrexed versus paclitaxel/carboplatin/bevacizumab followed by maintenance bevacizumab in patients with advanced non-small-cell lung cancer of nonsquamous histology
- Ralph Zinner
- , Scott Saxman
- , Guangbin Peng
- , Matthew Monberg
- , Waldo Ortuzar
Producción científica: Article › revisión exhaustiva
13
Citas
(Scopus)